This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brenner S, Matz H (1999) Improvement in androgenic alopecia in 53–76 year old men using oral finasteride. Int J Dermatol 38:928–30
Cunliffe WJ (1989) Non-acne disorders of the pilosebaceous unit, hidradenitis suppurativa. In: Cunliffe W (ed) Acne. Martin Dunitz, London, pp 87–92
Drapier-Faure E (1998) Traitement hormonal des hyperandrogenies. Reprod Hum Hormones 11:80–8
Farrell AM, Randall VA, Vafaee T, Dawber RPR (1999) Finasteride as a therapy for hidradenitis suppurativa. Br J Dermatol 141:1138–9
Fuhrmann J, Krattenmacher R, Slater E, Fritzmeier KH (1996) The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential. Contraception 54:243–51
Hammerstein J, Meckies J, Leo-Rossberg I, Moltz L, Zielske F (1975) Use of cyproterone acetate in the treatment of acne, hirsutism and virilism. J Ster Biochem 6:827–36
Joseph MA, Javaseelan E, Ganapathi B, Stephen J (2005) Hidradenitis suppurativa treated with finasteride. J Dermatol Treat 16:74–8
Moore C, Luderschmidt C, Moltz L, Oettel M, Klinger G, Schreiber G (1999) Antiandrogenic properties of the dienogest-containing oral contraceptive Valette®. Drugs Today 35:S69–S78
Mortimer PS, Dawber RPR, Gales MA, Moore RA (1986) A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 115:263–8
O’Brien RC, Cooper ME, Murray RML, Seeman E, Thomas AK, Jerums G (1991) Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism. J Clin Endocrinol Metabol 72:1008–13
Raudrant D, Rabe T (2003) Progestogens with antiandrogenic properties. Drugs 63:563–92
Rittmaster RS (1995) Medical treatment of androgen-dependent hirsutism. J Clin Endocrinol Metab 80:2559–63
Sawers RS, Randall VA, Ebling FJB (1986) Control of hidradenitis suppurativa in women using combined anti-androgen (cyproterone acetate) and oestrogen therapy. Br J Dermatol 115:269–74
Sitruk-Ware R (2004) Pharmacological profile of progestins. Maturitas 47:277–83
Stanczyk FZ (2002) Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception. Rev Endocr Metab Disord 3:211–24
Terouane B, Paris F, Servant N, Georget V, Sultan C (2002) Evidence that chlormadinone acetate exhibits antiandrogenic activity in androgen-dependent cell line. Mol Cell Endocrinol 198:143–7
Thorneycroft IH (1999) Update on androgenicity. Am J Obstet Gynecol 180:S288–S94
Vexiau P, Boudou P, Fiet J, Hardy N, Conard J, Consoli S, Abramovici Y, Cathelineau G (1995) 17β Estradiol: oral or parenteral administration in hyperandrogenic women? Metabolic tolerance in association with cyproterone acetate. Fertil Steril 63:508–15
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Drapier-Faure, E., Faure, M. (2006). Antiandrogens. In: Jemec, G.B.E., Revuz, J., Leyden, J.J. (eds) Hidradenitis Suppurativa. Springer, Berlin, Heidelberg . https://doi.org/10.1007/978-3-540-33101-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-540-33101-8_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33100-1
Online ISBN: 978-3-540-33101-8
eBook Packages: MedicineMedicine (R0)